Coherent Market Insights01.19.21
According to Coherent Market Insights, the global tissue and organ transplantation market is estimated to be valued at $13.9 billion in 2020 and is expected to exhibit a compound annual growth rate (CAGR) of 9.1 percent during the forecast period (2020-2027).
The global tissue and organ transplantation market is expected to witness significant growth, owing to increasing R&D activities in tissue transplantation. For instance, in May 2019, researchers from AMALNA Consulting and RMIT University, in collaboration with Tithon Biotech Inc., predicted the characteristic frequencies related to parathyroid hormone activities, particularly differentiation of stem cells into osteoblasts. The research findings can aid in development of improved techniques for differentiation of stem cells in tissue transplantation and repair.
Similarly, in December 2018, the study "Pathological Process of Prompt Connection between Host and Donor Tissue Vasculature Causing Rapid Perfusion of the Engineered Donor Tissue after Transplantation," published in the journal MDPI International Journal of Molecular Sciences, found that donor myocardial cell sheets including endothelial cell networks and potent pericytes could connect to host vasculature causing rapid donor tissue perfusion within 24 hours after transplantation.
Manufacturers are focusing on new product development, mergers and acquisitions, and collaborations to expand their current product portfolio and strengthen their market position. For instance, in September 2016, Stryker Corporation acquired Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for ankle, foot, and upper extremity procedures.
For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, which provides high strength and support to restore stability in capsular reconstruction.
The global tissue and organ transplantation market is expected to exhibit a CAGR of 9.1 percent during the forecast period (2020-2027), owing to the governments and NGOs taking initiatives to encourage people to donate organs. For instance, in April 2020, Human Resource & Services Administration launched Hospital Organ Donor Campaign in the United States.
North America is expected to be the most lucrative region in the tissue and organ transplantation market due to the rising number of transplants in the United States. For instance, according to the health resources and service administration, in 2019, a total of 39,718 transplants were performed in the United States.
Key players operating in the global tissue and organ transplantation market include CryoLife Inc., Folio Biosciences, Arthrex, Abbvie Inc., Zimmer Biomet, Medtronic plc, Novartis AG, Stryker Corporation, BiolifeSolutions Inc., Teva Pharmaceuticals, and Veloxis Pharmaceutical.
The global tissue and organ transplantation market is expected to witness significant growth, owing to increasing R&D activities in tissue transplantation. For instance, in May 2019, researchers from AMALNA Consulting and RMIT University, in collaboration with Tithon Biotech Inc., predicted the characteristic frequencies related to parathyroid hormone activities, particularly differentiation of stem cells into osteoblasts. The research findings can aid in development of improved techniques for differentiation of stem cells in tissue transplantation and repair.
Similarly, in December 2018, the study "Pathological Process of Prompt Connection between Host and Donor Tissue Vasculature Causing Rapid Perfusion of the Engineered Donor Tissue after Transplantation," published in the journal MDPI International Journal of Molecular Sciences, found that donor myocardial cell sheets including endothelial cell networks and potent pericytes could connect to host vasculature causing rapid donor tissue perfusion within 24 hours after transplantation.
Manufacturers are focusing on new product development, mergers and acquisitions, and collaborations to expand their current product portfolio and strengthen their market position. For instance, in September 2016, Stryker Corporation acquired Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for ankle, foot, and upper extremity procedures.
For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, which provides high strength and support to restore stability in capsular reconstruction.
The global tissue and organ transplantation market is expected to exhibit a CAGR of 9.1 percent during the forecast period (2020-2027), owing to the governments and NGOs taking initiatives to encourage people to donate organs. For instance, in April 2020, Human Resource & Services Administration launched Hospital Organ Donor Campaign in the United States.
North America is expected to be the most lucrative region in the tissue and organ transplantation market due to the rising number of transplants in the United States. For instance, according to the health resources and service administration, in 2019, a total of 39,718 transplants were performed in the United States.
Key players operating in the global tissue and organ transplantation market include CryoLife Inc., Folio Biosciences, Arthrex, Abbvie Inc., Zimmer Biomet, Medtronic plc, Novartis AG, Stryker Corporation, BiolifeSolutions Inc., Teva Pharmaceuticals, and Veloxis Pharmaceutical.